Lung Cancer

Particularly because of the continuing popularity of recreational substances that are known to have carcinogenic qualities, lung cancer is a serious health care concern for Americans which should be treated with great seriousness by prospective patients and practicing health care professionals. In understanding the risks that a possible occurrence of lung cancer may pose to you, health care consumers in the United States should pay especially close attention to the general finding that up to one fourth of the people who contract the condition of lung cancer exhibit no lung cancer symptoms up to the point when the lung cancer is diagnosed. In such cases of a late diagnosis, the absence of obvious lung cancer symptoms can make the task of dealing with and treating the cancer far more difficult for both the physician involved in the case and the individual in question whose health and life is at risk. These cases will allow treatment to take place aimed at dealing with the individual’s lung cancer after the performance of a seemingly unrelated procedures, such as most commonly a chest x-ray aimed at some other health issue, uncovers lung cancer symptoms. In considering and understanding the likely development of a case of lung cancer, it should be noted by concerned individuals that the majority of lung cancer patients are founded to manifest evident lung cancer symptoms in time for treatment to begin early.

Lung cancer symptoms proceed from such disruptive effects of the affliction on the body as the direct results of the primary tumor, to the actions that metastasis tumors take in attacking other parts of the human body, or to the unstable operations induced in the functioning of systems of the body such as those related to blood or hormones. In the event that primary lung cancers develop in the individual, some of the possible lung cancer symptoms of this particular condition could include the person starting to cough up blood, coughing normally, or discovering that he or she is experienced alarming levels of difficulty with breathing. Any occurrence of blood being coughed up should be counted as a possible lung cancer symptom and thus treated as an instance for heightened concern. Likewise, a person who is a habitual smoker or was a habitual smoker at one time should attend carefully to any indication that she or he is developing a new kind of cough.

Metastasis tumors may occur as symptoms in some thirty to forty percent of lung cancer patients. When it afflicts the liver or the adrenal glands it usually does not result in any symptoms that can be detected in time for effective treatment, but when striking the bones or the brain may be quickly detected through symptoms indicated by changes in functioning. The least directly related lung cancer symptoms are referred to as paraneoplastic syndromes and are those caused by chemicals that are released by the cancer, possibly including anemia, the deposition of new skin in the fingers, weight loss, fatigue and low sodium.

Prostate Cancer

In the array of techniques and tools that the health care industry has created to aid in the treatment of men who are manifesting prostate cancer, a commonly employed method for detecting prostate cancer symptoms is dependent on the analysis of a measurement standard for the human body based on a substance called prostate-specific antigen (PSA). Since the early discovery of prostate-specific antigens, the substance has been widely used by both health care professionals involved in treating patients dealing with prostate cancer and men who are facing the prospect of the same condition having a disastrous effect on their health and life. The discovery of this example of prostate cancer symptoms was accomplished by a researcher named Dr. Richard Ablin, who is based out of the University of Arizona. His research lent the substance its name and made a commonly recognized sign to look for to indicate the development of prostate cancer by finding that its occurrence was commonly linked to the occurrence of the condition. In the early months of 2010, however, Dr. Ablin spoke out against the current use of PSA that emphasized it as a primary indication among prostate cancer symptoms, referring to the widespread reliance on the detection of rising levels in prostate specific antigen as a “health care disaster.” Men who are currently dealing with the affliction of prostate cancer or who wish to be well prepared for future possible encounters with the disease that they may encounter would be well advised to attend to Ablin’s thoughts on this matter and if necessary to discuss them with their personal physicians in order to determine what his conclusions mean for the future of PSA as a primary tool for picking up prostate cancer symptoms.

Ablin’s critique of the current use made of prostate specific antigen levels have been reported in the media as being comprised of two essential points. The first is that though prostate specific antigen can indeed be used to pick up a direct indication of the occurrence of prostate cancer, it can also be caused by other causes. The varying other possible influences on the levels of prostate specific antigen levels for any individual man can include a benign enlargement that occurs in most men after a certain age, the infection of the prostate, and sex that takes place within forty eight hours of a prostate specific antigen test. Dr. Ablin warns against the unnecessary distress that may be raised by the detection of elevated prostate specific antigen levels being directly linked to an occurrence of prostate cancer.

A second area of concern that has been raised by Ablin with regard to current methods for detecting prostate cancer is the fact that in many cases where a cancer actually is detected by PSA tests the individual affected may not be in any great danger from the condition. He has pointed out that prostate cancer most often does not develop to malignant levels and should not be automatically met with potentially dangerous treatments.

Breast Cancer

In the array of techniques and tools that have been created by the health care industry for the purpose of treating women whose lives are being threatened by occurrences of breast cancer, a particularly central strategy lies in the method for tracking the progress being made and level of seriousness attained by the condition that is dependent on looking for breast cancer symptoms in the lymph nodes of a patient. This means for meeting and dealing with the challenge of treating breast cancer is based on the scientific finding that breast cancer is most likely to first go to the lymph nodes of a patient who is afflicted by the condition. The seriousness of the issue of breast cancer is suggested by the finding, as reported on the website for the leading anti-breast cancer foundation Susan G. Komen for the Cure, over 192,000 women living in the United States are discovered and reported each year to be exhibiting breast cancer symptoms. The efforts that have been made by the American health care establishment of physicians and researchers to meet the treatment and recovery needs of this large health care group have had some limited results. Though the appearance of breast cancer symptoms continues to rise in the number of new cases that are reported, research into the field found shortly before the most recent discovery, in 2010, that mortality rates for women with breast cancer, at least in the white population of the United States, had slightly fallen. This study of the rates of mortality related to breast cancer guarded against any overly optimistic interpretation of the findings by cautioning that the data also suggested that rates for black and Hispanic women had slightly risen over the course of the last three decades.

One positive factor in the development of techniques for helping breast cancer patients survive their body’s struggle with the disease that has been put to use in recent decades is the promotion of mammography. This tool, though highly useful, cannot be counted on for effectiveness in the case of every patient. Common breast cancer symptoms include changes that occur in the appearance or feel of a breast, including soreness and swelling. After a physician has managed to determine that a woman is manifesting breast cancer symptoms, one of the first places for the treatment to be taken is the determination that the cancerous agents have not spread to the lymph nodes, which will often be the first place that a cancer will “want” to attack, and that can allow the cancer access to a means for the body to distribute defense agents throughout itself and for a route into the bloodstream of a body. Because of the centrality of the lymph node system in effective defending against breast cancer, physicians have long been concerned with the issue of finding a procedure that will effectively and accurately identify the lymph nodes affected. The new agent has the advantage of more quickly leaving the body than older methods.

Cancer Research

New cancer research that has been conducted on the probable outcome of cases of colon cancer for people who develop the condition suggests a new factor to be accorded consideration when weighing the probable future of a person who has survived a brush with colon cancer. This new factor for understanding the progress of colon cancer is weight, which according to a study which was released in March 2010 through the pages of the journal Clinical Cancer Research is substantially tied in by statistical data to the probable survival of a person who has encountered the cancer. This new cancer research should provide a new means for thinking about the potential risks faced by a person who is faced with a diagnosis of colon cancer. In particular, it has been used by some researchers and physicians to suggest that one useful strategy for people who do have to face a struggle with the disease is to think about the weight they could lose and how that might affect their chances for surviving the cancer.

This program of cancer research was conducted at the Mayo Clinic in Rochester and involved a number of almost 4,400 patients being treated for the condition. The statistical figures which came out of this research indicated a tendency for obese colon cancer patients to be far more at risk than patients who had attained and were able to maintain more traditionally recommended levels of weight. These findings of the cancer research study produced particularly strong and indicative results for male patients, which researchers have speculated stems from the fact that male bodies are more prone to storing additional body weight in the belly. With these considerations in mind, the study showed obese colon cancer patients to be one-quarter to one-third more likely to die compared to individuals at a healthy weight level.

Despite this strongly suggestive finding, the researchers who conducted the cancer research have cautioned that the study suggests that a relationship exists between the chances of survival from colon cancer and the level of weight exhibited by a person, but that it is too soon to reach a conclusive summary of whether these factors directly bear on each other. The research attempted to maintain a level of applicability to this form of cancer by focusing on individuals manifesting Stage II or Stage III cancer, in which the effects of the disease have penetrated deeply into either the colon wall or into lymph nodes that are located nearby. Adjusting for other relevant factors in the rate of survival of colon cancer, which includes age and the stage to which the disease has progressed, showed that men who were very obese manifested a tendency to die of the disease that was thirty five times more great than that of men at a normal level of weight. One potential blind side that has been acknowledged by the researchers to exist in this cancer research study is consideration of factors like diet and exercise.